Back to top
more

Heska Corporation (HSKA)

(Delayed Data from NSDQ)

$79.28 USD

79.28
71,295

+3.36 (4.43%)

Updated May 3, 2019 04:00 PM ET

After-Market: $79.10 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

[HSKA]

Reports for Purchase

Showing records 41 - 60 ( 64 total )

Industry: Medical - Biomedical and Genetics

Record: 41

10/21/2014

Company Report

Pages: 7

Q3 2014 Veterinary Practice Survey - 268 veterinarians

Provider: Feltl & Company

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 42

07/31/2014

Company Report

Pages: 9

Q2 results well ahead of expectations, raise target.

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 43

07/21/2014

Company Report

Pages: 7

Q2 2014 Veterinary Practice Survey -420 veterinarians

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 44

05/09/2014

Company Report

Pages: 8

Reported Q1 results, reiterating STRONG BUY, $14.50 price target

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 45

04/24/2014

Company Report

Pages: 7

Q1 2014 Veterinary Practice Survey - 614 veterinarians

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 46

04/24/2014

Company Report

Pages: 7

Q1 2014 Veterinary Practice Survey - 614 veterinarians

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 47

03/28/2014

Company Report

Pages: 8

reports record Q4 results, upgrading to STRONG BUY, $14.50 price target

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 48

01/30/2014

Company Report

Pages: 7

Q4 2013 Veterinary Practice Survey; lower to BUY

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 49

11/07/2013

Company Report

Pages: 8

Beats handily on EPS; new sales strategy getting traction, reiterate SB

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 50

10/16/2013

Company Report

Pages: 7

Q3 2013 Veterinary Practice Survey

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 51

09/20/2013

Company Report

Pages: 7

Element POC blood gas and electrolyte analyzer introduced, reiterate SB, $9.50PT

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 52

08/08/2013

Company Report

Pages: 9

As expected, Q2 results sloppy; new sales strategy getting traction, reiterate SB

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 53

07/22/2013

Company Report

Pages: 7

Q2 2013 Veterinary Practice Survey

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 54

05/15/2013

Company Report

Pages: 10

Challenged Q1 2013 with numerous moving parts, yet opportunities remain

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 55

04/22/2013

Company Report

Pages: 7

Q1 2013 Veterinary Practice Survey and weather impact analysis

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 56

02/26/2013

Company Report

Pages: 9

Q4 ahead of expectations, transformational acquisition announced, PT to $12.50

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 57

01/28/2013

Company Report

Pages: 7

Q4 Veterinary Practice Survey and NAVC take-aways

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 58

11/14/2012

Company Report

Pages: 8

Challenging quarter; placements strong; accretive acquisitions in the pipeline?

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 59

10/15/2012

Company Report

Pages: 7

Q3 Veterinary Practice Survey - 110 veterinarians

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 60

10/03/2012

Company Report

Pages: 7

Element DC chemistry analyzer launched, should improve competitive position

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party